Geographical Group Reporting Submission

Group Cochrane Sweden

Name Martin Ringsten

Activity name / title Guideline production and support

Which function does this relate to?

Tier one Disseminate Cochrane reviews locally

Tier two Contribute to Cochrane’s priority setting work

Tier three Undertake local knowledge translation activities

Tier four Increase access of Cochrane evidence in different languages

Evidence production Cochrane review and evidence production

Date

Start date 01-01-2025

Proposed end date 30-11-2025

on-going No

Person to contact if any queries about this activity Martin Ringsten
martin.ringsten@med.lu.se

Type of activity Priority setting, Dissemination / Knowledge Translation, Contributions or improvements to health-related policy on local or national levels

Please give additional activity details (i.e., reach, impact, duration, return on investment) Cochrane Sweden have during 2025 been involved as both evidence synthesis teams or/and chairs in three different guidelines.
- Canadian guidelines for post-covid-19 condition. Finished during 2025. https://canpcc.ca/about-us/
- Swedish guideline on caffeine in preterm infants. Ongoing.
- Lancet commission on Maternal and newborn health. Initiating. https://www.lunduniversity.lu.se/article/new-global-initiative-maternal-and-newborn-health-be-led-sweden

Link and documents

By checking this box, my center consents to the use of these photos for Cochrane internal and external purposes, such as websites, reports, social media, etc. No